Posted on January 26, 2023
Today’s trade is focused on the Danish flank of the globalist criminal entourage, of which at this very late hour you’re already familiar.
It’s the Bagsvaerd-based Novo-Nordisk pharma giant (NYSE:NVO) who’s in our cross-hairs, and, as the map below shows: they’ve gone to great lengths to hide their totalitarian aims by situating themselves on the edge of the NORTH SEA, some 1245 kilometers from the center of planetary evil in DAVOS.
Have a look—
We’re not fooled, of course, by deliberate attempts to distract and divert us from TRUTH.
And it won’t be long before the entire planet is aware of Novo Nordisk’s role in the globalist plan for world domination.
But enough journalism!
So let’s have a gander at NOV’s fundamentals…
And you wanna buy this…?
We’re with you, Juan Carlo.
The stock has gained 52% in just four months and is set to announce earnings next Wednesday.
Our take is that the better part of NVO’s gains are attributable to an aggressive share buyback program that was initiated last February, 2022, and that will have run its course by the time earnings are revealed next week.
In other words, the jig is up, and the downside now awaits.
G-d bless you, all good Jews and Noahides.
Many happy returns!